CLDN4 and cancer: Therefore, a combination of the positive and negative markers, including at least two mesothelial cell markers (D2-40, calretinin, WT1) and two cancer cell markers (TTF-1, CEA, polyclonal, claudin-4), is recommended for the diagnosis of DMPM (29).